Epic Sciences Raises $42M In First Close Of Series F Financing To Advance Comprehensive Profiling For Metastatic Cancer Patients
Amount Raised
$42 Million
Round Type
Series F
Foster CityBiotechnologyHealth CareTherapeuticsBiopharmaDescription
Epic Sciences, Inc. ("Epic" or "Epic Sciences"), a privately held diagnostics company, has completed a $43 million first close of its Series F financing. The company will use the capital from this additional round of private investment to continue to advance its multi-omic platform and expand operations in areas such as single-cell sequencing and data analytics infrastructure.
Quick answer
Gilead Sciences raised $42 Million in a Series F round, dated June 1, 2022. Gilead Sciences is based in Foster City, California, United States.
- How much did Gilead Sciences raise?
- Gilead Sciences raised $42 Million in a Series F round on June 1, 2022.
- What does Gilead Sciences do?
- Gilead Sciences, Inc. is a biopharmaceutical company that has pursued and achieved breakthroughs in medicine for more than three decades, with the goal of creating a healthier world for all people.
- Where is Gilead Sciences based and how big is it?
- Gilead Sciences is based in Foster City, California, United States. Fundz records about 17,000 employees.
- Who are the decision-makers at Gilead Sciences?
- Fundz holds 1 contact at Gilead Sciences, including the Chairman and Chief Executive Officer. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Therapeutics and Biopharma around the same time
Companies in the same sectors as Gilead Sciences that raised within 45 days of this round, from Fundz verified event records.
- Renibus Therapeutics raised $15M on July 15, 2022.
- Tempest Therapeutics raised $15M on May 11, 2022.
- Entero Therapeutics raised $300K (Seed) on July 15, 2022.
- BIOVIE INC. raised $6M on July 15, 2022.
- Gossamer Bio raised $120M on July 15, 2022.
- Gossamer Bio raised $120M (Post-IPO Equity) on July 13, 2022.
Who to call at Gilead Sciences, and when
A new round usually means Gilead Sciences is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Gilead Sciences raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Gilead Sciences, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Gilead Sciences. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Gilead Sciences raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Gilead Sciences raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.